Skip to Content
Home > Care & Treatment > Payson Center for Cancer Care > Clinical Trials > Clinical Trials Search Results
The study will find out if adding Herceptin to breast radiation therapy is more effective than radiation therapy alone in preventing occurrence of breast cancer in the same breast, the other breast or in other parts of the body in patient who are Her2 neu positive.
A study to learn if adding Herceptin to standard chemotherapy treatment in patients with low levels of Her2 will help prevent breast cancer from returning and extend life expectancy.
Compare the side effects between trastuzumab emtansine and paclitaxel in combination with trastuzumab. It is believed the trastuzumab emtansine will be lower.
© 2013 Concord Hospital